China develops nanomaterial to combat COVID-19: Report

A team of Chinese scientists has reportedly developed a novel way to combat the new coronavirus that causes the Covid-19 disease which has killed over 32,000 people globally.

According to Global Times, the new weapon is not a drug or a compound but some nanomaterial.

“Chinese scientists have developed a new weapon to combat the #coronavirus,” the news portal tweeted on Sunday.

“They say they have found a nanomaterial that can absorb and deactivate the virus with 96.5-99.9 per cent efficiency,” it added.

Nanomaterials are used in a variety of manufacturing processes, products and healthcare including paints, filters, insulation and lubricant additives.

In healthcare, Nanozymes are nanomaterials with enzyme-like characteristics.

According to the US NIH, scientists have not unanimously settled on a precise definition of nanomaterials, but agree that they are partially characterized by their tiny size, measured in nanometers.

“Nanotechnology can be used to design pharmaceuticals that can target specific organs or cells in the body such as cancer cells, and enhance the effectiveness of therapy,” said NIH.

However, while engineered nanomaterials provide great benefits, “we know very little about the potential effects on human health and the environment. Even well-known materials, such as silver for example, may pose a hazard when engineered to nano size,” according to NIH.

  • Related Posts

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Patients for Patient Safety Foundation (PFPSF) Partners with CAHO to RollOut an Excellence Program New Delhi: Thanks to some well-meaning organizations, patients are going to be lord of all they…

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Medicines that cure Us are making Our Environment Sick

    Medicines that cure Us are making Our Environment Sick